Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms DFCI 006, DFCI006 |
Target |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors), HCK inhibitors(Tyrosine-protein kinase HCK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary Central Nervous System Lymphoma | Preclinical | US | 10 Dec 2023 | |
Waldenstrom Macroglobulinemia | Preclinical | US | 10 Dec 2023 |